After nearly a year, venture capitalists nabbed their first U.S. acquisition for more than a billion dollars. And it wasn’t a tech startup. Nor was it a company on the list of known unicorns. And it had nothing to do with blockchain.
{iframe}https://techcrunch.com/2018/01/20/startup-fundraising-and-exits-look-bullish-for-bio-and-health/{/iframe}